This author has yet to write their bio.Meanwhile lets just say that we are proud old admin contributed a whooping 84 entries.
April 20, 2020 at 11:00 AM EST Bloomberg Intelligence and inThought will host a call with immunology experts Thurs., Apr 20th at 11AM EST to discuss development of a Covid-19 therapy and how best to interpret clinical data once they begin to emerge.
April 2, 2020 at 11:00 AM EST / 4:00 PM BST Please join Bloomberg Intelligence healthcare analysts and inThought Research for a discussion with two vaccine experts, who will share their views on the prospects for developing a vaccine against the novel coronavirus. We will discuss specific programs as well as general considerations for mRNA […]
March 24, 2020 Impact: Moderate FDA has announced that it will postpone or cancel all non-essential meetings through April 30, 2020 due to COVID-19. The following meetings are affected: April 21, 2020: FDA Pulmonary-Allergy Drugs AdCom to discuss Trelegy Ellipta sNDA for IMPACT trial results (GlaxoSmithKline). April 22, 2020: FDA AdCom (undetermined) to discuss sNDA […]
March 20, 2020 Impact: High Regeneron and Sanofi have announced the initiation of a U.S. phase 2/3 trial evaluating anti-IL6 mAb Kevzara (sarilumab) in patients hospitalized with severe COVID-19 infection, to begin at medical centers in New York. The adaptive design trial is expected to enroll up to 400 patients. The first part will evaluate […]
With conventions and other events are taking precautions amid the COVID-19 outbreak, some conferences are postponing, while others are providing virtual-only access. Companies are restricting travel for employees, preventing conference attendance. Speakers are unable to attend conventions as many leading academic institutions have restricted physician travel for months.
